# Safety and Efficacy of Adding Intravenous N-acetyl Cysteine in Colon Surgeries

> **NCT03589495** · PHASE4 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 60 (actual)

## Conditions studied

- Systemic Inflammatory Response Syndrome

## Interventions

- **DRUG:** N Acetyl L Cysteine
- **OTHER:** dextrose 5%

## Key facts

- **NCT ID:** NCT03589495
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07-30
- **Primary completion:** 2016-10-15
- **Final completion:** 2016-10-15
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2018-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03589495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03589495, "Safety and Efficacy of Adding Intravenous N-acetyl Cysteine in Colon Surgeries". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03589495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*